Interestingly, an increase in circulating CD31+/CD41b− expressing MP and decrease in FMD manifests during COPD exacerbations7,16, suggesting a potential mechanism linking the increased risk of cardiovascular event following exacerbation1. Here, PECAM1 is linked to chronic obstructive pulmonary disease.